These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24900152)

  • 1. The Clinical Role of Dual-Time-Point (18)F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma.
    Lee S; Park T; Park S; Pahk K; Rhee S; Cho J; Jeong E; Kim S; Choe JG
    Nucl Med Mol Imaging; 2014 Jun; 48(2):121-9. PubMed ID: 24900152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of focal hypermetabolic thyroid incidentaloma: An analysis with F-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters.
    Lee H; Chung YS; Lee JH; Lee KY; Hwang KH
    World J Clin Cases; 2022 Jan; 10(1):155-165. PubMed ID: 35071515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
    Kim BH; Kim SJ; Kim H; Jeon YK; Kim SS; Kim IJ; Kim YK
    Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
    Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF
    Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of
    Wu B; Zhang Y; Tan H; Shi H
    Abdom Radiol (NY); 2019 Jul; 44(7):2430-2435. PubMed ID: 30944961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-time point
    Parghane RV; Basu S
    Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid Incidentalomas on
    Makis W; Ciarallo A
    Mol Imaging Radionucl Ther; 2017 Oct; 26(3):93-100. PubMed ID: 28976331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT).
    Familiar C; Merino S; Valhondo R; López C; Pérez X; De Los Monteros PE; Hernández F; Pazos M; Pallarés R; Pascual AC
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70(3):171-178. PubMed ID: 37030900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative assessment of malignant potential of gastrointestinal stromal tumor by dual-time-point 18F-fluorodeoxyglucose positron emission tomography imaging: Usefulness of standardized uptake value and retention index.
    Kwon Y; Park E; Pahk K; Kim S; Kim MJ; Graf D; Park S
    J Cancer Res Ther; 2019; 15(1):142-147. PubMed ID: 30880770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of malignant thyroid lesions on [
    Nasr H; Farghaly H; Alqarni A; Al-Salem S; Sayed M
    Eur J Radiol Open; 2021; 8():100373. PubMed ID: 34458507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of standardized uptake value in differentiation between benign and malignant thyroid lesions detected incidentally in 18F-FDG PET/CT examination.
    Stangierski A; Woliński K; Czepczyński R; Czarnywojtek A; Lodyga M; Wyszomirska A; Janicka-Jedyńska M; Bączyk M; Ruchała M
    PLoS One; 2014; 9(10):e109612. PubMed ID: 25296297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.
    Higashi T; Saga T; Nakamoto Y; Ishimori T; Mamede MH; Wada M; Doi R; Hosotani R; Imamura M; Konishi J
    J Nucl Med; 2002 Feb; 43(2):173-80. PubMed ID: 11850481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K
    J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.
    Chun AR; Jo HM; Lee SH; Chun HW; Park JM; Kim KJ; Jung CH; Mok JO; Kang SK; Kim CH; Kim BY
    Endocrinol Metab (Seoul); 2015 Mar; 30(1):71-7. PubMed ID: 25325277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-phase 18F-fluoro-2-deoxy-D-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer.
    Lyshchik A; Higashi T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):389-97. PubMed ID: 15372209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cell proliferation in renal cell carcinoma using dual-phase
    Onishi R; Noguchi M; Kaida H; Moriya F; Chikui K; Kurata S; Kawahara A; Kage M; Ishibashi M; Matsuoka K
    Oncol Lett; 2015 Aug; 10(2):822-828. PubMed ID: 26622577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical value of texture analysis of dual-time-point
    Nakajo M; Jinguji M; Aoki M; Tani A; Sato M; Yoshiura T
    Eur Radiol; 2020 Mar; 30(3):1759-1769. PubMed ID: 31728684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.